92nd General Assembly, 2nd Regular Session

HB 1222

  
Provides additional health insurance coverage for clinical trials for cancer treatment by adding phase I and II to the currently covered phase III and IV clinical trials.
Sponsor: Schaaf, Rob (028)
Co-Sponsor: Holand, Roy (135) ... et al.
Proposed Effective Date: 8/28/2004
LR Number: 3866L.01I
Last Action: 02/05/2004 - Referred: Financial Services (H)
Bill String: HB 1222
Next House Hearing: Hearing not scheduled
Calendar: Bill currently not on a House calendar

Bill Text

3866L.01I

Bill Summary

Bill Summary
HB1222I
Archived Documents